Bank Of Montreal Vbi Vaccines Inc Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$0.29 - $0.64 $10,134 - $22,366	34,947 New	34,947 $10,000
Q4 2022 Feb 01, 2023	SELL	$0.38 - $22.5 $1,900 - $112,500	-5,000 Reduced 22.44%	17,280 $6,000
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $108 - $3,486	-149 Reduced 0.66%	22,280 $18,000
Q2 2022 Aug 11, 2022	SELL	$0.66 - $1.81 $1,073 - $2,944	-1,627 Reduced 6.76%	22,429 $20,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $368 - $716	-290 Reduced 1.19%	24,056 $40,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $4,406 - $6,420	1,994 Added 8.92%	24,346 $59,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $58,799 - $78,120	-21,000 Reduced 48.44%	22,352 $74,000
Q2 2021 Aug 12, 2021	BUY	$2.61 - $4.17 $113,148 - $180,777	43,352 New	43,352 $146,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.